Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1615219 · FYE Dec 31 · Prices AT CLOSE 2026-08-27 (USD) Last $2.97 · Day −1.33% · Mkt cap $2M · Off 52W high −82.4% · Vol (1Y) 163.9% Price2026-01-08 → 2026-08-27 DCOY close: $9.2 on 2026-01-08 to $3.0 on 2026-08-27. Split-adj closes · 150 of 150 · price returnⓘ At a glance | Short interest1.6% of sh out | | Days to cover1.0d | | Top-10 13F concentration100.0% | | Next report (est.)2026-11-16 |
SI 2026-08-14 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$14.4M | | ROE−338.3% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns No return windows available for DCOY. Risk | Ann. volatility (1Y)163.9% | | Ann. volatility (3Y)163.9% | | Sharpe (1Y)−0.46 | | Sharpe (3Y)−0.46 | | Max drawdown (1Y)−80.2% | | Max drawdown (3Y)−80.2% |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Tower Research Capital LLC (TRC) | 1,021 | $6,668 | 0.19% | new | | UBS Group AG | 546 | $3,566 | 0.10% | new | | Advisory Services Network, LLC | 41 | $268 | 0.01% | new | | MORGAN STANLEY | 1 | $7 | 0.00% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-12 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-12 | −$4.46 | — | $227,629 | — | | 2026-03-31 | 2026-05-08 | −$4.18 | — | — | — | | 2025-09-30 | 2025-11-14 | −$1.81 | — | — | — | | 2025-06-30 | 2025-07-31 | — | — | $0 | — |
As-reported XBRL · next 2026-11-16 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
